Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sliding Perception Of CER Importance Not Concerning To PCORI’s Selby

Executive Summary

PCORI Executive Director Joe Selby says decline in perception that comparative effectiveness research is “very important” to stakeholders in annual National Pharmaceutical Council survey “makes sense,” adding that results offer a realistic appraisal of expectations on the future of CER.

You may also be interested in...



CER “Substantial Impact” Expected in Three-to-Five Years: NPC’s Annual Comparative Effectiveness Survey

CER is slowly beginning to enter the public lexicon. Respondents to the National Pharmaceutical Council annual survey on comparative effectiveness report being more familiar with CER now than two years ago; but they still see the major impact several years away – not right on the horizon.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

UsernamePublicRestriction

Register

PS055220

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel